Old Web
English
Sign In
Acemap
>
authorDetail
>
Marie_Paule Derde
Marie_Paule Derde
EA Digital Illusions CE
Medicine
Bevacizumab
Oncology
Physical therapy
Internal medicine
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized phase I study comparing the pharmacokinetics of a bevacizumab (HD204) biosimilar to European Union- and United States of America-sourced bevacizumab.
2021
PLOS ONE
Martin Demarchi
Pierre Coliat
Philippe Barthélémy
R. Schott
M. Benabdelghani
Michael Kim
Jocelyn hii
Peggy Feyaerts
Felicia Ang
Marie_Paule Derde
Filip Deforce
Thierry Petit
Christopher Schwabe
Chris Wynne
Lisa Soyeon Park
Xavier Pivot
Show All
Source
Cite
Save
Citations (0)
Assessment of quality and clinical similarity (pharmacokinetic and safety) of HD204, a biosimilar of bevacizumab.
2020
Journal of Clinical Oncology
Jocelyn hii
Martin Demarchi
Pierre Coliat
Michael J. Kim
Kuo Wei Chan
Peggy Feyaerts
Felicia Ang
R. Schott
Philippe Barthélémy
Meher Benabdelghani
Filip Deforce
Marie_Paule Derde
Xavier Pivot
Lisa Soyeon Park
Show All
Source
Cite
Save
Citations (0)
Establishing analytical and clinical similarity between HD201 and herceptin.
2020
Journal of Clinical Oncology
Jocelyn hii
Xavier Pivot
Kristi Mclendon
Kuo Wei Chan
Peggy Feyaerts
Jeong Hyeon Lee
Felicia Ang
Martin Demarchi
Pierre Coliat
Filip Deforce
Marie_Paule Derde
Michael J. Kim
Lisa Soyeon Park
Show All
Source
Cite
Save
Citations (0)
1